Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lung Bioengineering
Silver Spring, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Lung Bioengineering's centralized EVLP service has enabled evaluation of over 800 lungs, resulting in over 500 successful transplants since 2014; this FDA-approved service expands organ availability by restoring and reevaluating lungs previously deemed unsuitable for transplant
- Therapeutic areas
- PulmonologyImmunology
- Modalities
- DeviceEx Vivo Organ Perfusion Technology
- Industry
- Therapeutic Medical Devices
02
Partnerships
XVIVO Perfusion AB (device partner providing XPS™ and STEEN Solution™ systems)Mayo Clinic (site of milestone transplants using LBE EVLP service)
Beyond the preview
Go deeper on Lung Bioengineering.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lung Bioengineering.